The impact of extramedullary disease (EMD) in AML on the outcomes of allogeneic hematopoietic cell transplantation (alloHCT) is unknown. Using data from the Center for International Blood and Marrow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback